Scenic Biotech Funding: $31M Raised, Series A (2022)
Scenic Biotech is based in Amsterdam, Netherlands. It has raised $31M in total funding. Latest round: Series A.
Scenic Biotech funding overview
Scenic Biotech is based in Amsterdam, Netherlands. Scenic Biotech has raised $31M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2022. The round record for Scenic Biotech runs through 2022; nothing later has been disclosed. Investors on record include Eir Ventures, BioMedPartners, Vesalius Biocapital, Inkef Capital, BioGeneration Ventures, Oxford Science Enterprises. 6 distinct backers are named across the disclosed rounds.
Scenic Biotech has raised $31M in total disclosed funding across the rounds on record.
Who has invested in Scenic Biotech?
Eir Ventures, BioMedPartners, Vesalius Biocapital, Inkef Capital, BioGeneration Ventures, Oxford Science Enterprises are named among the investors backing Scenic Biotech.
What was the latest Scenic Biotech funding round?
The most recent disclosed round is a Series A, announced in March 2022.
Where is Scenic Biotech based?
Scenic Biotech is based in Amsterdam, Netherlands.
When did Scenic Biotech last raise?
The last disclosed Scenic Biotech round closed in March 2022 at Series A.
We update the Scenic Biotech record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Amsterdam and their backers are listed below.
